Prof Stephen Chan is a leading consultant oncologist at Nottingham City Hospital, where he is also Director of Clinical Trials in breast cancer and gynaecological cancer.
His innovative and dynamic cancer research is renowned throughout the world for its advances in understanding and treating cancer, and he has held numerous international lectures about his results and findings. His research and medical expertise is focused particularly on breast cancer and gynaecological cancer, and he holds a profound knowledge in treating these conditions with chemotherapy and radiotherapy.
His educatory background is substantial and the specialist nature of the work he carries out at Nottingham Oncology is evident through this.
Prof Chan qualified as a doctor at the Nottingham University Medical School and went on to focus his medical training in oncology through research and training at Oxford University.
His cancer expertise was further heightened by his oncogenes research project at Cambridge MRC and the Imperial College London which allowed him a better, more influential understanding of the complex disease. He previously worked as a cancer consultant at the Christie Hospital Manchester before returning to Nottingham to take on a post at the Nottingham City Hospital in 1989 – a post which he still holds there today.
Between 1995 and 2000 Prof Chan chaired the Mid Trent postgraduate educational board, overseeing the management and clinical performance of cancer treatments throughout the Nottinghamshire area.
More information is available on Professor Chan’s website.
Consultant Oncologist, Nottingham City Hospital.
British Breast Group.
British Gynaecological Cancer Group.
ASCO American Society of Clinical Oncology.
EORTC Breast and Gynaecological Cancer Groups.
Scottish Gynaecological Cancer Group.